The Nanomedicine Market research reveals compelling evidence of clinical superiority across multiple therapeutic domains where conventional treatments have reached performance plateaus. Nanoparticle formulations of established chemotherapy agents demonstrate significantly improved tumor penetration, reduced cardiotoxicity, and enhanced patient tolerance compared to original...